A
Arne M. van Heusden
Researcher at Erasmus University Rotterdam
Publications - 15
Citations - 944
Arne M. van Heusden is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Pregnancy & Pregnancy rate. The author has an hindex of 11, co-authored 14 publications receiving 900 citations.
Papers
More filters
Journal ArticleDOI
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences
TL;DR: The FSH threshold and window concept for in vivo follicle growth, and the concept of monofollicle growth in anovulatory patients, are described.
Journal ArticleDOI
Hysteroscopy before in-vitro fertilisation (inSIGHT): a multicentre, randomised controlled trial
Janine G. Smit,Jenneke C. Kasius,Marinus J.C. Eijkemans,Carolien A.M. Koks,Ronald J T van Golde,Annemiek W. Nap,G.J. Scheffer,Petra A. P. Manger,Annemieke Hoek,Benedictus C. Schoot,Arne M. van Heusden,Walter K. H. Kuchenbecker,Denise A. M. Perquin,Kathrin Fleischer,Eugenie M. Kaaijk,Alexander V. Sluijmer,Jaap Friederich,Ramon H. M. Dykgraaf,Marcel H.A van Hooff,Leonie A. Louwe,Janet Kwee,Corry H. de Koning,Ineke C. A. H. Janssen,Femke Mol,Ben W.J. Mol,Frank J. M. Broekmans,Helen L. Torrance +26 more
TL;DR: Routine hysteroscopy does not improve livebirth rates in infertile women with a normal transvaginal ultrasound of the uterine cavity scheduled for a first IVF treatment and should not be offered, according to a pragmatic, multicentre, randomised controlled trial.
Journal ArticleDOI
The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years
TL;DR: Patients aged > or = 40 years with a good response to COH have a good prognosis for IVF treatment and the age limit for acceptance of patients should not be set at 40 years, instead the response toCOH can be used to predict candidates likely to have a successful IVF outcome.
Journal ArticleDOI
A triplet pregnancy after in vitro fertilization is a procedure-related complication that should be prevented by replacement of two embryos only
TL;DR: The obstetric outcome of triplets pregnancies in the population indicates that triplet pregnancies after IVF treatment have to be prevented, and replacement of two embryos only gives acceptable IVF results and is the method chosen in the IVF program in Rotterdam to prevent triplet pregnancy.
Journal ArticleDOI
The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial.
Theodora C. van Tilborg,Marinus J.C. Eijkemans,Joop S.E. Laven,Carolien A.M. Koks,Jan Bruin,Gabrielle J. Scheffer,Ron J. T. van Golde,Kathrin Fleischer,Annemieke Hoek,Annemiek W. Nap,Walter K. H. Kuchenbecker,Petra A. P. Manger,Egbert A. Brinkhuis,Arne M. van Heusden,Alexander V. Sluijmer,Arie Verhoeff,Marcel H.A van Hooff,Jaap Friederich,Jesper M. J. Smeenk,Janet Kwee,Harold R. Verhoeve,Cornelis B. Lambalk,F.M. Helmerhorst,Fulco van der Veen,Ben W.J. Mol,Helen L. Torrance,Frank J.M. Broekmans +26 more
TL;DR: This study aims to assess whether an individualised FSH dose regime based on an ovarian reserve test (ORT) is more cost-effective than a standard dose regime and compares cost-effectiveness of the three dose-adjustment strategies to aStandard dose strategy.